wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36378038-DC4D0D6A-31DE-4DCC-B92E-9380087D17EB
Q36378038-DC4D0D6A-31DE-4DCC-B92E-9380087D17EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36378038-DC4D0D6A-31DE-4DCC-B92E-9380087D17EB
Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.
P2860
Q36378038-DC4D0D6A-31DE-4DCC-B92E-9380087D17EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36378038-DC4D0D6A-31DE-4DCC-B92E-9380087D17EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1cda1392dc2c437b38b07cd22347521053b42d9
P2860
A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets.